NasdaqGS - Nasdaq Real Time Price USD
Voyager Therapeutics, Inc. (VYGR)
3.1700
-0.2600
(-7.58%)
At close: May 9 at 4:00:02 PM EDT
3.3300
+0.16
+(5.05%)
After hours: May 9 at 7:12:20 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-111,972
-15,310
77,919
-12,509
-53,525
Investing Cash Flow
42,407
-94,859
-141,643
-7,339
65,906
Financing Cash Flow
1,241
114,015
33,645
1,110
612
End Cash Position
77,629
74,241
70,395
100,474
119,212
Capital Expenditure
-2,038
-3,521
-3,256
-2,491
-1,609
Issuance of Capital Stock
0
112,778
31,121
0
0
Free Cash Flow
-114,010
-18,831
74,663
-15,000
-55,134
12/31/2021 - 11/11/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DNLI Denali Therapeutics Inc.
14.37
-0.42%
WVE Wave Life Sciences Ltd.
6.59
+0.69%
RGNX REGENXBIO Inc.
7.52
+5.17%
STOK Stoke Therapeutics, Inc.
9.36
+3.43%
MGNX MacroGenics, Inc.
1.4300
-7.14%
QURE uniQure N.V.
12.79
+4.41%
SLDB Solid Biosciences Inc.
2.7600
-0.36%
SAGE Sage Therapeutics, Inc.
6.56
-2.24%
ORIC ORIC Pharmaceuticals, Inc.
5.08
-4.51%
LXEO Lexeo Therapeutics, Inc.
2.6900
-10.33%